Page last updated: 2024-11-12

a 85783.0

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

A 85783.0: a platelet activating factor antagonist; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9957997
CHEMBL ID98318
MeSH IDM0246119

Synonyms (21)

Synonym
CHEMBL98318 ,
bdbm50035397
6-(4-fluoro-phenyl)-3-((r)-3-pyridin-3-yl-1h-pyrrolo[1,2-c]thiazole-7-carbonyl)-indole-1-carboxylic acid dimethylamide
161395-33-1
(r)-6-(4-fluorophenyl)-n,n-dimethyl-3-[3-(3-pyridinyl)-1h,3h-pyrrolo[1,2-c]thiazol-7-yl]carbonyl-1h-indole-1-carboxamide
a-85783
unii-ocs3j46f47
a 85783.0
a-85783.0
DTXSID20433311
6-(4-fluorophenyl)-n,n-dimethyl-3-[(3r)-3-pyridin-3-yl-1,3-dihydropyrrolo[1,2-c][1,3]thiazole-7-carbonyl]indole-1-carboxamide
(r)-6-(4-fluorophenyl)-n,n-dimethyl-3-(3-(3-pyridinyl)-1h,3h-pyrrolo(1,2-c)thiazol-7-yl)carbonyl-1h-indole-1-carboxamide
1h-indole-1-carboxamide, 6-(4-fluorophenyl)-n,n-dimethyl-3-(((3r)-3-(3-pyridinyl)-1h,3h-pyrrolo(1,2-c)thiazol-7-yl)carbonyl)-
OCS3J46F47 ,
J-009822
(r)-6-(4-fluorophenyl)-3-[3-(3-pyridyl)-1h,3h-pyrrolo[1,2-c]thiazol-7-oyl]indole-1 carboxylic acid dimethylamide
1h-indole-1-carboxamide, 6-(4-fluorophenyl)-n,n-dimethyl-3-[[(3r)-3-(3-pyridinyl)-1h,3h-pyrrolo[1,2-c]thiazol-7-yl]carbonyl]-
CS-0113256
PD163522
HY-133200
(r)-6-(4-fluorophenyl)-n,n-dimethyl-3-(3-(pyridin-3-yl)-1h,3h-pyrrolo[1,2-c]thiazole-7-carbonyl)-1h-indole-1-carboxamide

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"Peripheral blood taken over 12 h after dosing was used for ex vivo beta-TG release and, in the case of the 70 mg dose, measurement of plasma drug concentration."( Ex vivo inhibition of beta-thromboglobulin release following administration to man of ABT-299, a novel prodrug of a potent platelet activating factor antagonist.
Albert, DH; Carter, GW; Kleinert, HD; Magoc, TJ; Menacherry, SD; Morgan, DW; Reyes, AE; Summers, JB; Sun, E, 1997
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID177706In vivo potency for inhibition of LPS-induced hypotension in rat by intra arterial (i.a.) administration1994Journal of medicinal chemistry, Dec-23, Volume: 37, Issue:26
N-(acyloxyalkyl)pyridinium salts as soluble prodrugs of a potent platelet activating factor antagonist.
AID165479Competitive binding with [3H]PAF to rabbit platelet membranes1994Journal of medicinal chemistry, Dec-23, Volume: 37, Issue:26
N-(acyloxyalkyl)pyridinium salts as soluble prodrugs of a potent platelet activating factor antagonist.
AID177705In vivo potency for complete inhibition of LPS-induced intestinal damage in rat by intravenous administration1994Journal of medicinal chemistry, Dec-23, Volume: 37, Issue:26
N-(acyloxyalkyl)pyridinium salts as soluble prodrugs of a potent platelet activating factor antagonist.
AID165635Inhibitory activity was determined in PAF-induced serotonin release from rabbit platelets1994Journal of medicinal chemistry, Dec-23, Volume: 37, Issue:26
N-(acyloxyalkyl)pyridinium salts as soluble prodrugs of a potent platelet activating factor antagonist.
AID177707In vivo potency for inhibition of PAF-induced cutaneous vascular permeability in rat by intravenous administration1994Journal of medicinal chemistry, Dec-23, Volume: 37, Issue:26
N-(acyloxyalkyl)pyridinium salts as soluble prodrugs of a potent platelet activating factor antagonist.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (83.33)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.10

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.10 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.18 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.10)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (16.67%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]